Helex Raises $3.5 Million Seed Round to Advance Gene Therapies for Kidney Diseases
PositiveArtificial Intelligence

Helex has successfully raised $3.5 million in a seed funding round aimed at advancing gene therapies for kidney diseases. This funding is significant as it will enable the company to further develop innovative treatments that could potentially transform the lives of patients suffering from these conditions. With kidney diseases affecting millions globally, Helex's efforts could lead to groundbreaking advancements in medical science and patient care.
— Curated by the World Pulse Now AI Editorial System



